Description: Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, France, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, and Yourgene Health segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The company was incorporated in 2006 and is based in Eastleigh, the United Kingdom.
Home Page: www.novacyt.com
York House
Eastleigh,
SO53 4DG
United Kingdom
Phone:
44 2380 748830
Officers
| Name | Title |
|---|---|
| Mr. Lyn Dafydd Rees | CEO & Executive Director |
| Mr. Steve Gibson | CFO & Director |
| Bryan Close | Chief Operations Officer |
| Dr. Joanne Mason | Chief Scientific Officer & Director |
| Mr. David Franks | Chief Human Resources Officer |
| Paul Oladimeji | Group Head of R&D |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4427 |
| Price-to-Sales TTM: | 2.1307 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 240 |